Predictors of kidney disease in a cohort of pediatric patients with lupus

Lupus

Volumn 24, Issue 8, 2015, Pages 862-868

  Sule, S D ^a   Moodalbail, D G ^b   Burnham, J ^c   Fivush, B ^a   Furth, S L ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

nephritis; Renal lupus; systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; SERUM ALBUMIN;

ABNORMAL LABORATORY RESULT; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; ADOLESCENT; AFRICAN AMERICAN; BLOOD; KIDNEY; LUPUS NEPHRITIS; ODDS RATIO; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; AFRICAN AMERICANS; AUTOANTIBODIES; CHILD; FEMALE; HUMANS; KIDNEY; LOGISTIC MODELS; LUPUS NEPHRITIS; MALE; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84930906726     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315570162     Document Type: Article

References (38)

1. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1993 ; 36: 348-354
2. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008 ; 152: 550-556
3. Font J, Cervera R, Espinosa G, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998 ; 57: 456-459
4. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995 ; 34: 866-872
5. Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008 ; 58: 556-562
6. Hagelberg S, Lee Y, Bargman J, et al. Long-term followup of childhood lupus nephritis. J Rheumatol. 2002 ; 29: 2635-2642
7. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 ; 64: 797-808
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725
9. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
10. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 ; 64: 2677-2686
11. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 ; 15: 241-250
12. Appenzeller S, Clark A, Pineau C, Vasilevsky M, Bernatsky S. Isolated pyuria in systemic lupus erythematosus. Lupus. 2010 ; 19: 793-796
13. Rahman P, Gladman DD, Ibanez D, Urowitz MB. Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus. Lupus. 2001 ; 10: 418-423
14. Chiewchengchol D, Murphy R, Morgan T, et al. Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. Rheumatology. 2014 ; 53: 1504-1512
15. Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001 ; 44: 2342-2349
16. Budhai L, Oh K, Davidson A. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus. J Clin Invest. 1996 ; 98: 1585-1593
17. Ho A, Barr SG, Magder LS, Petri M. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2001 ; 44: 2350-2357
18. Gunnarsson I, Sundelin B, Heimburger M, et al. Repeated renal biopsy in proliferative lupus nephritis - predictive role of serum C1q and albuminuria. J Rheumatol. 2002 ; 29: 693-699
19. Walz LeBlanc BA, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus - predictors of clinical flares. J Rheumatol. 1994 ; 21: 2239-2241
20. Harley JB, Scofield RH, Reichlin M. Anti-Ro in Sjogren's syndrome and systemic lupus erythematosus. Rheum Dis Clin North Am. 1992 ; 18: 337-358
21. Buyon JP, Hiebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998 ; 31: 1658-1666
22. Mond CB, Peterson MG, Rothfield NF. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum. 1989 ; 32: 202-204
23. Shahin AA, Shahin HA, Hamid MA, Amin MA. Cardiac involvement in patients with systemic lupus erythematosus and correlation of valvular lesions with anti-ro/SS-A and anti-la/SS-B antibody levels. Mod Rheumatol. 2004 ; 14 (2). 117-122
24. Moon SJ, Park HS, Kwok SK, et al. Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy. Lupus. 2013 ; 22: 527-537
25. Chien JW, Lin CY, Yang LY. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi (Taipei). 2001 ; 64: 283-291
26. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000 ; 35: 904-914
27. Ronnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 408-420
28. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003 ; 197: 711-723
29. Manzi S, Navratil JS, Ruffing MJ, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum. 2004 ; 50: 3596-3604
30. Singh V, Mahoney JA, Petri M. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 1989-1993
31. Chan RW, Lai FM, Li EK, et al. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis. Nephrol Dial Transplant. 2006 ; 21: 1534-1540
32. Kiani AN, Johnson K, Chen C, et al. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol. 2009 ; 36: 2224-2230
33. Suzuki M, Wiers KM, Klein-Gitelman MS, et al. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008 ; 23: 403-412
34. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol. 2005 ; 16: 467-473
35. Brunner HI, Mueller M, Rutherford C, et al. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 2577-2584
36. Pitashny M, Schwartz N, Qing X, et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum. 2007 ; 56: 1894-1903
37. Rubinstein T, Pitashny M, Levine B, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology. 2010 ; 49: 960-971
38. Hinze CH, Suzuki M, Klein-Gitelman M, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009 ; 60: 2772-2781